Login
Toggle navigation
Videos
Categories
Trending
Andrew Wilkinson, co-founder of Tiny Capital and WeCommerce, discussed WeCommerce's recent trading debut on CNBC with Scott Wapner.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Jordan Taub is the CEO of WeCommerce Holdings.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Glenn August on Building Oak Hill: Scaling Success in Private Credit |Glenn August , CEO, Oak Hill Advisors.
00:10:00
"Building Trust through CEFEX Certification | Carlos Panksep, Managing Director, Centre for Fiduciary Excellence (CEFEX)"
00:10:00
Customer Testimonial: Concurrent Technologies | Miles Adcock, CEO, Concurrent Technologies PLCCNC:LSE
00:10:00
Marc Halbfinger, CEO of PCCW Global speaks on the continuous advancements in technology,|Mr Li was appointed an Executive Director and the Chairman of PCCW
00:10:00
VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners
00:10:00
Tal Jacobson, Perion CEO, joins 'Squawk Box' to discuss Snap's quarterly earnings results and market implications.
00:10:00
Peter Lewis Reflects on His Family Background and Idyllic Childhood in Riverdale and Great Neck
00:10:00
"RIT Capital Partners: Leveraging Centuries of Financial Expertise for Modern Investment Mastery"
00:10:00
"1970s Market Déjà Vu - A Dialogue with Jim Rogers " | Ronald Chan, Chartwell Capital Limited
00:10:00
Presentation on Namibian Critical Metals Portfolio
00:10:00
Driving Ambition of EMIS Group | Andy Thorburn, CEO, EMIS Group PLCEMIS:LSE
00:10:00
4DS Memory (ASX:4DS): A non-volatile memory for the fast-growing Artificial Intelligence (AI) market | David McAuliffe, CEO, 4DS Memory Ltd4DS:ASX